Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Clinical Chemistry|February 24, 2009
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survivalPauliina Helo, Angel M Cronin, Daniel C Danila, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
European Urology|November 27, 2016
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal TherapyMeike Adam, Pierre Tennstedt, Dominik Lanwehr, et al.
European Urology Focus|March 16, 2024
Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in GermanyPhilipp Mandel, Benedikt Hoeh, Clara Humke, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
European Urology|June 19, 2022
Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided SurgerySophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al.
European Urology|October 3, 2006
Development and external validation of an extended 10-core biopsy nomogramFelix K-H Chun, Alberto Briganti, Markus Graefen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
The American Journal of Pathology|June 19, 2012
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancerAntje Krohn, Tobias Diedler, Lia Burkhardt, et al.
The Journal of Urology|August 21, 2010
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stageLars Budäus, Hendrik Isbarn, Christian Eichelberg, et al.
Clinical Chemistry|February 24, 2009
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survivalPauliina Helo, Angel M Cronin, Daniel C Danila, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
European Urology|November 27, 2016
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal TherapyMeike Adam, Pierre Tennstedt, Dominik Lanwehr, et al.
European Urology Focus|March 16, 2024
Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in GermanyPhilipp Mandel, Benedikt Hoeh, Clara Humke, et al.
Pageof 21